ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 56 filers reported holding ENZON PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $17,000 | -32.0% | 25,604 | -1.1% | 0.00% | – |
| Q3 2015 | $25,000 | -19.4% | 25,892 | +1.1% | 0.00% | – |
| Q2 2015 | $31,000 | -63.5% | 25,601 | -68.0% | 0.00% | – |
| Q1 2015 | $85,000 | -18.3% | 79,939 | -16.6% | 0.00% | – |
| Q4 2014 | $104,000 | -4.6% | 95,839 | -5.1% | 0.00% | – |
| Q3 2014 | $109,000 | +34.6% | 100,943 | +29.4% | 0.00% | – |
| Q2 2014 | $81,000 | +92.9% | 78,030 | +93.0% | 0.00% | – |
| Q1 2014 | $42,000 | -23.6% | 40,427 | -14.3% | 0.00% | – |
| Q4 2013 | $55,000 | -8.3% | 47,167 | +32.7% | 0.00% | – |
| Q3 2013 | $60,000 | +87.5% | 35,543 | +122.0% | 0.00% | – |
| Q2 2013 | $32,000 | -89.2% | 16,007 | -79.5% | 0.00% | – |
| Q1 2013 | $296,000 | – | 77,926 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALGERT GLOBAL LLC | 124,891 | $85,000 | 0.04% |
| Icahn Capital | 5,904,863 | $4,030,000 | 0.01% |
| SEIZERT CAPITAL PARTNERS, LLC | 414,810 | $283,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 473,708 | $323,000 | 0.01% |
| Anson Funds Management LP | 25,000 | $17,000 | 0.01% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 106,908 | $72,000 | 0.01% |
| Spark Investment Management LLC | 57,500 | $39,000 | 0.01% |
| Renaissance Technologies | 3,501,585 | $2,390,000 | 0.01% |
| Concert Wealth Management Inc. | 45,938 | $30,000 | 0.00% |
| CSS LLC/IL | 96,572 | $66,000 | 0.00% |